79 related articles for article (PubMed ID: 9407465)
1. Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II.
Wu LL; Yang N; Roe CJ; Cooper ME; Gilbert RE; Atkins RC; Lan HY
Kidney Int Suppl; 1997 Dec; 63():S221-5. PubMed ID: 9407465
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II.
Yu XQ; Wu LL; Huang XR; Yang N; Gilbert RE; Cooper ME; Johnson RJ; Lai KN; Lan HY
Kidney Int; 2000 Oct; 58(4):1469-80. PubMed ID: 11012882
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring.
Klahr S; Morrissey JJ
Kidney Int Suppl; 1997 Dec; 63():S111-4. PubMed ID: 9407436
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
5. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney.
Yang N; Wu LL; Nikolic-Paterson DJ; Ng YY; Yang WC; Mu W; Gilbert RE; Cooper ME; Atkins RC; Lan HY
Nephrol Dial Transplant; 1998 Aug; 13(8):1967-74. PubMed ID: 9719149
[TBL] [Abstract][Full Text] [Related]
6. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
7. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction.
Vaziri ND; Bai Y; Ni Z; Quiroz Y; Pandian R; Rodriguez-Iturbe B
J Pharmacol Exp Ther; 2007 Oct; 323(1):85-93. PubMed ID: 17636006
[TBL] [Abstract][Full Text] [Related]
8. Endogenous angiotensin II and the reflex response to stimulation of cardiopulmonary serotonin 5HT3 receptors.
Veelken R; Hilgers KF; Scrogin KE; Mann JF; Schmieder RE
Br J Pharmacol; 1998 Dec; 125(8):1761-7. PubMed ID: 9886768
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II formation in the kidney and nephrosclerosis in Ren-2 hypertensive rats.
Hartner A; Porst M; Klanke B; Cordasic N; Veelken R; Hilgers KF
Nephrol Dial Transplant; 2006 Jul; 21(7):1778-85. PubMed ID: 16522658
[TBL] [Abstract][Full Text] [Related]
10. The renal antifibrotic effects of angiotensin-converting enzyme inhibition involve bradykinin B2 receptor activation in angiotensin II-dependent hypertension.
Seccia TM; Belloni AS; Guidolin D; Sticchi D; Nussdorfer GG; Pessina AC; Rossi GP
J Hypertens; 2006 Jul; 24(7):1419-27. PubMed ID: 16794493
[TBL] [Abstract][Full Text] [Related]
11. Glomerular mRNA expression of angiotensinase A after renal ablation.
Wolf G; Thaiss F; Mueller E; Disser M; Pooth R; Zahner G; Stahl RA
Exp Nephrol; 1995; 3(4):240-8. PubMed ID: 8590037
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
[TBL] [Abstract][Full Text] [Related]
13. Valsartan inhibited the accumulation of dendritic cells in rat fibrotic renal tissue.
Wu K; Zhou T; Sun G; Wang W; Zhang Y; Zhang Y; Hao L; Chen N
Cell Mol Immunol; 2006 Jun; 3(3):213-20. PubMed ID: 16893502
[TBL] [Abstract][Full Text] [Related]
14. Kidney angiotensin receptors and their role in renal pathophysiology.
Sandberg K; Ji H
Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
[TBL] [Abstract][Full Text] [Related]
15. Regulation of angiogenic factors in angiotensin II infusion model in association with tubulointerstitial injuries.
Kitayama H; Maeshima Y; Takazawa Y; Yamamoto Y; Wu Y; Ichinose K; Hirokoshi K; Sugiyama H; Yamasaki Y; Makino H
Am J Hypertens; 2006 Jul; 19(7):718-27. PubMed ID: 16814127
[TBL] [Abstract][Full Text] [Related]
16. Interactions between renin angiotensin system and advanced glycation in the kidney.
Thomas MC; Tikellis C; Burns WM; Bialkowski K; Cao Z; Coughlan MT; Jandeleit-Dahm K; Cooper ME; Forbes JM
J Am Soc Nephrol; 2005 Oct; 16(10):2976-84. PubMed ID: 16107577
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor blockade and progression of nondiabetic-mediated renal disease.
Tarif N; Bakris GL
Kidney Int Suppl; 1997 Dec; 63():S67-70. PubMed ID: 9407425
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair.
Weber KT
Semin Nephrol; 1997 Sep; 17(5):467-91. PubMed ID: 9316215
[TBL] [Abstract][Full Text] [Related]
19. Increased osteopontin expression following renal ablation is attenuated by angiotensin type 1 receptor antagonism.
Cao Z; Cox A; Bonnet F
Exp Nephrol; 2002; 10(1):19-25. PubMed ID: 11803201
[TBL] [Abstract][Full Text] [Related]
20. [Protective effect of catechin on renal microvessels in 5/6 nephrectomized rats and its mechanism].
Cao Y; He XJ; Xiang W; Yi ZW
Zhong Xi Yi Jie He Xue Bao; 2009 Jun; 7(6):557-62. PubMed ID: 19583939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
